Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Relapse of acute myeloid leukemia at the pituitary gland: a case report and review of literature.

Lin HW, Shih SR, Yao M, Huang TS.

Endocr Pathol. 2012 Sep;23(3):172-6. doi: 10.1007/s12022-012-9203-1. Review. No abstract available.

PMID:
22527946
2.

Idarubicin, high-dose cytarabine and etoposide for remission induction in therapy-related acute myeloid leukemia.

Philpott N, Mehta J, Treleaven J, Powles R.

Leuk Lymphoma. 1994 Sep;15(1-2):127-30.

PMID:
7858489
3.

[Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].

Miyawaki S.

Rinsho Ketsueki. 2014 Jan;55(1):31-41. Review. Japanese. No abstract available.

PMID:
24492035
4.

Bilateral breast relapse in acute myelogenous leukemia.

Monteleone PM, Steele DA, King AK, Konefal S, Kelleher JF.

J Pediatr Hematol Oncol. 2001 Feb;23(2):126-9. Review.

PMID:
11216705
6.

Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.

Lee SH, Abebe L, Paietta E, Einzig A, Wiernik PH.

Am J Hematol. 2009 Jul;84(7):455-7. doi: 10.1002/ajh.21431. Review. No abstract available.

7.

Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.

Sackmann-Muriel F, Fernández-Barbieri MA, Santarelli MT, Matus-Ridley M, Rosso A, Negri-Aranguren P, Cerutti I, Gomel M, Kvicala R.

Semin Oncol. 1993 Dec;20(6 Suppl 8):34-8.

PMID:
8290970
8.

Long-term propylthiouracil use and acute myeloid leukemia: a case report and review of the literature.

Focosi D, Caracciolo F, Galimberti S, Papineschi F, Petrini M.

Ann Hematol. 2008 Mar;87(3):233-5. Epub 2007 Sep 11. Review. No abstract available.

PMID:
17846771
9.

[Successful treatment with idarubicin in a pediatric case of t(8;21) acute myelogenous leukemia with additional chromosomal abnormalities at relapse].

Wakazono Y, Kataoka A, Fusaoka T, Tunamoto K.

Rinsho Ketsueki. 1998 Jul;39(7):499-505. Japanese.

PMID:
9750457
10.

FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.

Candoni A, Simeone E, Tiribelli M, Malagola M, Russo D, Fanin R.

Am J Hematol. 2009 Oct;84(10):690-2. doi: 10.1002/ajh.21516. No abstract available.

11.

Idarubicin in combination with etoposide and cytarabine in adult acute non-lymphoblastic leukaemia (ANLL).

Carella AM, Pungolino E, Piatti G, Giordano D, Cerri R, Risso M, Nati S.

Bone Marrow Transplant. 1989 Jan;4 Suppl 1:50-1. No abstract available.

PMID:
2713562
12.

Treatment of relapsed and refractory acute myeloid leukemia in adults.

Lazzarino M, Morra E, Alessandrino EP, Merante S, Bernasconi P, Bonfichi M, Caldera D, Bernasconi C.

Bone Marrow Transplant. 1989 Jan;4 Suppl 1:121-3. Review. No abstract available.

PMID:
2653487
13.

Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia.

Leahey AM, Bunin NJ, Belasco JB, Meek R, Scher C, Lange BJ.

Med Pediatr Oncol. 2000 May;34(5):313-8.

PMID:
10797352
14.

[IL-2 post-autologous transplant of hematopoietic stem cells].

Rayon C.

Sangre (Barc). 1997 Apr;42 Suppl 1:37. Spanish. No abstract available.

PMID:
9381299
15.

Autologous bone marrow transplantation for patients with acute myelogenous leukemia in complete remission.

Meloni G, De Fabritiis P, Petti MC, Pulsoni A, Sandrelli A, Covelli A, Simone F, Mandelli F.

Ann N Y Acad Sci. 1987;511:483-8. No abstract available.

PMID:
3326477
16.

Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results.

Ferrara F, Izzo T, Criscuolo C, Riccardi C, Celentano M, Mele G.

Am J Hematol. 2010 Sep;85(9):687-90. doi: 10.1002/ajh.21791.

17.
18.

[Second marrow transplantation following high dose busulfan, etoposide, and Ara-C after testicular relapse in a patient with AML].

Matsue K, Tohi T, Masauji N, Tsukuda K.

Rinsho Ketsueki. 1992 Mar;33(3):338-42. Japanese.

PMID:
1578638
19.

Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS.

de Witte T, Suciu S, Verhoef G, Labar B, Archimbaud E, Aul C, Selleslag D, Ferrant A, Wijermans P, Mandelli F, Amadori S, Jehn U, Muus P, Boogaerts M, Zittoun R, Gratwohl A, Zwierzina H, Hagemeijer A, Willemze R.

Blood. 2001 Oct 15;98(8):2326-31. Erratum in: Blood 2002 Mar 1;99(5):1535.

20.

Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.

Hofmann WK, Heil G, Zander C, Wiebe S, Ottmann OG, Bergmann L, Hoeffken K, Fischer JT, Knuth A, Kolbe K, Schmoll HJ, Langer W, Westerhausen M, Koelbel CB, Hoelzer D, Ganser A.

Ann Hematol. 2004 Aug;83(8):498-503. Epub 2004 May 20.

PMID:
15156346

Supplemental Content

Support Center